Correlation Engine 2.0
Clear Search sequence regions


  • beta Catenin (5)
  • bone marrow cells (2)
  • cck 8 (1)
  • cellular (1)
  • DKK1 (1)
  • female (1)
  • glycoproteins (2)
  • GPNMB (15)
  • marrow (10)
  • MSCs (9)
  • osteoblasts (1)
  • osteogenesis (2)
  • osteoporosis (6)
  • protein rat (1)
  • rat (5)
  • stem cells (2)
  • western blot (1)
  • Wnt (4)
  • Sizes of these terms reflect their relevance to your search.

    The efficacy of anti-osteoporotic treatments is still limited. Our study aimed to investigate the effect of extracellular vesicles (EVs) derived from bone marrow-derived MSCs (BMSCs) overexpressing glycoprotein non-melanoma clone B (GPNMB) on osteoporosis (OP). Lentiviral vector for GPNMB overexpression or its negative control was generated and transfected into BMSCs. EVs enriched with GPNMB (GPNMB-EVs) were extracted from GPNMB-modified BMSC-conditioned medium and then identified. Cellular uptake and proliferation were analyzed using the Dil-labeled assay and CCK-8 assay, respectively. Cytochemical staining, western blot, and RT-qPCR analysis were performed to assess the effect of GPNMB-EVs on osteogenic differentiation of BMSCs in vitro. Dickkopf-1 (DKK1) as the inhibitor was applied to explore the Wnt/β-catenin signaling pathway involved in the GPNMB-EV-induced osteogenic differentiation. In vivo experiments were conducted using an ovariectomized (OVX) rat model of postmenopausal osteoporosis, and then assessed the effect of GPNMB-EVs by micro-CT, and histological and immunohistochemical assays. GPNMB-EVs were taken up by BMSCs, and they noticeably promoted the proliferation of BMSCs. Additionally, GPNMB-EVs activated the Wnt/β-catenin signaling to stimulate osteogenesis in BMSCs. In vivo examination showed that GPNMB-EVs remarkably improved trabecular bone regeneration and alleviated the osteoporotic phenotype in the OVX-induced rat model of OP. EVs derived from GPNMB-modified BMSCs significantly stimulated the proliferation and osteogenic differentiation of BMSCs via the activation of Wnt/β-catenin signaling and attenuated the bone loss in the OVX-induced rat model of OP. Our findings suggest the promising potential of GPNMB-EVs as cell-free therapy for the treatment of OP. Copyright © 2021 Elsevier Inc. All rights reserved.

    Citation

    Ba Huang, Yongwei Su, Enpu Shen, Meng Song, Danping Liu, Hui Qi. Extracellular vesicles from GPNMB-modified bone marrow mesenchymal stem cells attenuate bone loss in an ovariectomized rat model. Life sciences. 2021 May 01;272:119208

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33582177

    View Full Text